U.S. Chemicals Stock News

Without a specific news headline driving Hancock Whitney (HWC) today, the stock still draws attention from investors who are reviewing recent returns, profitability figures, and its current share price of US$67.17. See our latest analysis for Hancock Whitney. Recent trading has been relatively steady, with a 1 month share price return of 4.77% and a year to date share price return of 4.20%, set against a 1 year total shareholder return of 28.01% that builds on a 109.91% total shareholder...

Roku (ROKU) has just opened 2026 earnings season with Q1 results that build on a clear turnaround in the numbers, capped by Q4 2025 revenue of about US$1.4b and basic EPS of US$0.54. Over the past year, quarterly revenue has moved from US$1,201.0m in Q4 2024 to US$1,394.9m in Q4 2025, while basic EPS shifted from a loss of US$0.24 to a profit of US$0.54. This sets up a story in which improving profitability sits at the center of the earnings debate, with margins in focus as investors weigh...

If you are wondering whether Cognizant Technology Solutions is attractively priced right now, the key is understanding what the current share price implies about its future. The stock last closed at US$52.43, after returns of a 4.9% decline over 7 days, 14.4% decline over 30 days, 35.5% decline year to date, 31.3% decline over 1 year, 12.9% decline over 3 years, and 24.1% decline over 5 years. Recent share price moves sit against a broader backdrop of ongoing interest in large IT services...

For investors considering whether Guardant Health at around US$87.60 represents fair value or a potential opportunity, this article examines what that price may indicate about the stock. The share price is US$87.60 after a 1.5% decline over the past week and a 3.9% decline over the past month. It is still up 87.0% over the past year and 270.4% over three years, while a 35.3% decline over five years provides additional context. Recent news about Guardant Health has highlighted its role in...

IDEAYA Biosciences (IDYA) is back in focus after the FDA agreed to review its New Drug Application for darovasertib plus crizotinib in first line metastatic uveal melanoma under a Real-Time Oncology Review program. See our latest analysis for IDEAYA Biosciences. Even with the FDA review decision and recent positive Phase 2/3 data, IDEAYA Biosciences’ share price has pulled back, with a 30 day share price return of a 13.21% decline and a year to date share price return of a 16.72% decline,...

Wondering whether Sportradar Group's current share price reflects its true worth, or if the market is mispricing the story. The stock last closed at US$13.26, with returns of 0.2% over 7 days, a 20.3% decline over 30 days, and year to date and 1 year returns of 43.1% and 44.1% declines, while the 3 year return sits at 1.8%. Recent coverage has focused on Sportradar Group as a listed sports data and technology provider, with attention on how it is positioned in the wider sports betting and...

Why TriNet Group is on investors’ radar today TriNet Group (TNET) has drawn attention after a period of mixed share performance, with a strong month and past week set against weaker returns over the past 3 months and year. See our latest analysis for TriNet Group. At a share price of US$44.47, TriNet Group’s recent 24% 30 day share price return contrasts with a 27% 90 day share price decline and a 44% 1 year total shareholder return loss, suggesting fading longer term momentum despite the...

Wondering if American Electric Power Company at about US$136.91 is offering fair value or if you might be paying over the odds? This article breaks down what the current pricing could mean for you. The stock last closed at US$136.91, with returns of 1.6% over 7 days, 4.0% over 30 days, 18.2% year to date, 31.4% over 1 year, 66.4% over 3 years, and 86.7% over 5 years. This provides useful context before assessing any valuation metrics. Recent trading interest has been shaped by ongoing...

APA stock performance snapshot APA (APA) has drawn fresh attention after recent trading, with the share price closing at US$40.13. The stock shows mixed short term moves, including a 1.5% decline over the past day and a 6.4% gain over the past week. See our latest analysis for APA. The recent 6.4% 7 day share price return, alongside a 90 day share price return of 51.9% and a 1 year total shareholder return of 154.0%, points to strong momentum despite short term pullbacks. If APA’s move has...

First Industrial Realty Trust expanded its board and appointed Frank E. Schmitz as an independent director. The move follows a recent activist investor campaign focused on board composition and governance. The appointment comes in a contested board setting, signaling a response to shareholder pressure. For investors watching NYSE:FR, this board change occurs at a time when the stock is trading at $62.14 and has returned 31.2% over the past year and 44.6% over the past five years. Those...

Gen Digital (NasdaqGS:GEN) has partnered with xAI to bring Grok large language models into its consumer platforms via the Gen AI Foundry. The company is launching VPN for Agents, presented as an industry first security tool tailored to autonomous AI agents. Gen Digital is also expanding Norton AI Agent Protection to address new cyber risks created by AI driven agents. Gen Digital, trading at $19.37, is adding these AI focused efforts on top of a share performance record that includes a...

Ultra Clean Holdings (NasdaqGS:UCTT) announced that Clarence Granger will step down as Chairman of the Board effective May 22, 2026. Tom Edman has been appointed to assume the Chairman role as the company adjusts its leadership at the board and executive levels. This change follows a period of executive transitions while the sector is influenced by increased AI related investment. Ultra Clean Holdings, trading at $74.61, has seen sharp share price moves recently, including a 10.1% decline...

Relay Therapeutics (RLAY) has drawn fresh attention after deciding to advance zovegalisib plus Pfizer’s atirmociclib into Phase 3 for PI3Ka-mutated, HR+/HER2- metastatic breast cancer, following early safety and response data in heavily pre-treated patients. See our latest analysis for Relay Therapeutics. The share price has been volatile around the latest zovegalisib update, with a 7 day share price return of negative 15.9%, following a 90 day share price return of 66.1% and a 1 year total...

Q1 results and digital-first push in focus for OFG Bancorp (OFG) OFG Bancorp (OFG) has been in focus after first quarter results topped Wall Street expectations, with management pointing to ongoing loan growth, steady credit performance, and disciplined expense management. See our latest analysis for OFG Bancorp. The share price has gained 11.3% over the past month and 13.5% over the past quarter. The 1 year total shareholder return of 13.8% and 3 year total shareholder return, which is about...

In April 2026, Range Resources reported first-quarter 2026 results showing daily production of about 1,508,842 Mcf of natural gas, 108,193 barrels of NGLs, 8,239 barrels of oil and total revenue of US$1,034.17 million, with net income of US$341.63 million and diluted EPS of US$1.44 from continuing operations. Alongside these stronger operational and financial results, new Schedule 13G filings reveal that Vanguard entities have built passive stakes above 5% of Range Resources’ outstanding...

In late April 2026, Johnson & Johnson reported strong first‑quarter results with revenue of US$24.06 billion, raised its full‑year sales outlook to US$100.30–US$101.30 billion, increased its quarterly dividend to US$1.34 per share, and advanced key therapies including IMAAVY (nipocalimab) receiving FDA Priority Review in warm autoimmune hemolytic anemia and CAPLYTA (lumateperone) gaining an expanded label for preventing schizophrenia relapse. These moves highlight Johnson & Johnson’s effort...

If you are wondering whether New Jersey Resources at around US$56 is offering good value today, it helps to step back and look at what the recent price and fundamentals are really telling you. The stock has recently closed at US$56, with returns of 0.3% over 7 days, 1.8% over 30 days, 21.8% year to date, 17.6% over 1 year, 23.4% over 3 years, and 54.5% over 5 years. This gives plenty of data points to weigh up how the market currently views its prospects and risks. Recent coverage around New...

Context for Helios Technologies after recent performance Helios Technologies (HLIO) has drawn renewed investor interest after a recent period where the stock showed mixed moves, with a 2.3% decline over the past week and a 2.2% decline over the past month. See our latest analysis for Helios Technologies. Despite the recent soft patch in the share price, with a 30 day share price return of a 2.18% decline, momentum over a longer window still reflects a 22.17% year to date share price gain and...

National Fuel Gas (NFG) has recently drawn investor attention after its share price closed at $82.98, with recent returns showing mixed moves over the past week, month, and past 3 months. Investors may now reassess its fundamentals. See our latest analysis for National Fuel Gas. The recent 1 day share price return of negative 1.66% extends a short term pullback, with the 30 day share price return of negative 10.65% contrasting with a 5 year total shareholder return of 84.62%. This suggests...

Recent moves in BKV (BKV) stock come as investors weigh two catalysts: the upcoming May 7, 2026 earnings release, which is expected to show lower earnings on higher revenue, and fresh interest from a prominent hedge fund. See our latest analysis for BKV. At a share price of $31.32, BKV has seen a 14.98% 1 month share price return and a 68.39% 1 year total shareholder return, suggesting momentum has picked up as investors focus on the upcoming earnings update and hedge fund interest. If you...

Granite Construction (GVA) is back in focus after Q1 2026 results showed stronger than expected revenue, a higher full year revenue outlook to US$5.2b to US$5.4b, and record backlog supported by acquisitions. See our latest analysis for Granite Construction. The stronger Q1 2026 update appears to have fed into the share price, with Granite Construction’s 7 day share price return of 13.01% and 30 day return of 13.98% adding to a 1 year total shareholder return of 72.64%. This suggests momentum...

If you are wondering whether Callaway Golf at around US$15.16 is still reasonably priced after its recent run, the valuation story is the key place to focus. The stock has seen sharp moves, with a 29.4% return year to date and 121.3% over the last year, set against a 32.1% decline over three years and a 51.3% decline over five years. These swings have kept Callaway Golf on many watchlists, as investors weigh shorter term momentum of 9.7% over the last 30 days against a 1% decline over the...

In late April 2026, Match Group announced a US$100,000,000 minority investment in Sniffies, a real-time map-based cruising app for queer men, with an option to fully acquire the platform while keeping it founder-led and operationally independent. This move, alongside ongoing efforts to court LGBTQ users after acquiring Her, indicates Match Group is broadening its portfolio toward more niche, community-focused dating and social experiences. We’ll now explore how Match Group’s US$100,000,000...

Without a specific news headline driving Excelerate Energy (EE) today, investors are focusing on the stock’s recent returns, its value score of 3, and the company’s role in global liquefied natural gas infrastructure. See our latest analysis for Excelerate Energy. At a share price of $34.47, Excelerate Energy’s recent 30-day share price return of 7.15% contrasts with a 90-day share price return decline of 7.71%. The 1-year total shareholder return of 35.40% and 3-year total shareholder return...